TGF-beta signaling blockade inhibits PTHrP secretion by breast cancer cells and bone metastases development.
about
Hypoxia and TGF-beta drive breast cancer bone metastases through parallel signaling pathways in tumor cells and the bone microenvironment.The biology of the Ets1 proto-oncogeneType III TGF-beta receptor-independent signalling of TGF-beta2 via TbetaRII-B, an alternatively spliced TGF-beta type II receptorBreast cancer bone metastasis mediated by the Smad tumor suppressor pathwayEpidermal growth factor signaling via Ras controls the Smad transcriptional co-repressor TGIF.Latent bone metastasis in breast cancer tied to Src-dependent survival signalsTransforming growth factor beta signaling impairs Neu-induced mammary tumorigenesis while promoting pulmonary metastasisGranulocyte colony-stimulating factor enhances bone tumor growth in mice in an osteoclast-dependent mannerTransforming growth factor-beta and breast cancer: Lessons learned from genetically altered mouse modelsTransforming growth factor-beta and breast cancer: Transforming growth factor-beta/SMAD signaling defects and cancer.Transforming growth factor-beta and breast cancer: Tumor promoting effects of transforming growth factor-betaMolecular biology of breast cancer metastasis. 'Has it spread?': disarming one of the most terrifying questionsMolecular biology of breast cancer metastasis. Genetic regulation of human breast carcinoma metastasis.Actions of bisphosphonates in animal models of breast cancerLead exposure inhibits fracture healing and is associated with increased chondrogenesis, delay in cartilage mineralization, and a decrease in osteoprogenitor frequency.Suppression of NADPH Oxidase Activity May Slow the Expansion of Osteolytic Bone MetastasesProstate cancer metastasis: roles of recruitment and reprogramming, cell signal network and three-dimensional growth characteristicsMolecular alterations that drive breast cancer metastasis to boneThe Roles of Epithelial-to-Mesenchymal Transition (EMT) and Mesenchymal-to-Epithelial Transition (MET) in Breast Cancer Bone Metastasis: Potential Targets for Prevention and TreatmentAt the crossroads: EGFR and PTHrP signaling in cancer-mediated diseases of boneTranscriptional control of cancer metastasisTGF-β/SMAD/GLI2 signaling axis in cancer progression and metastasisBone specific immunity and its impact on metastasisRole of Parathyroid Hormone-Related Protein Signaling in Chronic PancreatitisTargeting tumor-stromal interactions in bone metastasisDoxorubicin-mediated bone loss in breast cancer bone metastases is driven by an interplay between oxidative stress and induction of TGFβCell density sensing alters TGF-β signaling in a cell-type-specific manner, independent from Hippo pathway activationQuantitative ex-vivo micro-computed tomographic imaging of blood vessels and necrotic regions within tumors.The role of the BMP signaling antagonist noggin in the development of prostate cancer osteolytic bone metastasisThe calcium-sensing receptor in the breast.Biology of bone metastases.Calcium-Sensing Receptor in Breast Physiology and CancerTumor cell dormancyMetastatic colonization by circulating tumour cellsTGF-β Signaling in Bone Remodeling and Osteosarcoma ProgressionSwitching Roles of TGF-β in Cancer Development: Implications for Therapeutic Target and Biomarker StudiesSmad2 and Smad3 have opposing roles in breast cancer bone metastasis by differentially affecting tumor angiogenesisTGFbeta primes breast tumors for lung metastasis seeding through angiopoietin-like 4TGFbeta in CancerModern pathogenetic concepts of liver fibrosis suggest stellate cells and TGF-beta as major players and therapeutic targets
P2860
Q21142766-F66BE2C1-5AF7-4B05-AB00-9AC01B7F9A7CQ21245748-7477ED47-D3E2-43FB-8AFA-84EE2D8F6A2FQ24290737-035D7254-084C-4F47-8E48-585E5027362FQ24536061-42AC8DD0-317A-4134-A0C4-F8F713F91815Q24540358-1AD943E6-40FC-4325-A8E6-C471F60AD6DDQ24648828-EA0F467D-7588-4030-815B-97CAB9C623AFQ24679619-F75DB7D6-E25F-416D-8CD3-72393F0D6828Q24683680-18F1ED9A-9B5D-4A19-BFEE-7A2BE40AE00BQ24793229-CDBEBF6F-43CD-46C4-BD16-98A6F677BC79Q24793265-05F96717-F538-4AC8-B5AE-17F1E82F74C8Q24793319-6A213A99-B817-448C-8919-CD4AF15FBA84Q24800902-649C3EAC-484E-4293-A63B-85959FA5E7D0Q24800958-5342A189-02A9-40CD-80BB-B9F31477DF74Q24802119-EC25A225-6AE5-4288-82CA-D37EA1BDC095Q24813247-DFBFB15B-8C10-47F3-9B10-58FE539EE267Q26738400-BA2E8FAA-E201-4FB7-8719-3548D2AC0AC1Q26773613-E990FE72-6592-4407-B484-3ACD6B8A975EQ26829858-EC52A815-6292-489C-B406-362AC28A3D01Q26865458-29E403EE-E240-476F-9F69-6BE46CB8AA22Q26866067-750EBB4C-8485-4643-89B4-E8B8DACEF2B6Q26992024-830E4A39-213D-4648-9A3C-2935E7E5A33FQ27008239-612A9413-7A85-4692-AFC3-DE8C37371F7DQ27022883-5B6AC97B-6EBB-4E72-AC8B-6C773620495FQ27023929-E9C08DF4-00DF-4269-AAC2-0B0EE7C90153Q27024561-CD5F3E45-8FC5-4407-B84A-45D81AE1345AQ27303597-1D804EC8-C673-45A3-916E-6458019F1429Q27314869-743E66CA-689B-4A4B-94B2-B3FBFA746178Q27330382-6351E9F8-C921-41C6-A0AF-EF7EC03E14A8Q27437809-37045707-904F-4ED6-A502-682BAB9C5FEDQ27691289-BBAAFB97-2F03-4EBE-B708-E0AC789D2055Q27693653-9AA49E19-3920-4592-8873-D1591505867EQ28071486-846B8013-9697-4CA4-8E12-1F1A5D2D2CEDQ28073065-C6A8668E-6DB7-441C-ADF0-4FF400FC8614Q28076164-ACD57BB2-11DA-493B-A3D8-B328CCCB1746Q28076815-A8982AEC-71CA-4453-833C-80BB9FB395C7Q28079488-689D3947-D075-4D4A-A4D5-C8844662B73FQ28267699-ED2DEAD1-69A1-4EB8-88D0-E65D5B529AC9Q28275478-28509538-58E7-4502-9C7A-86DC7A38F554Q28288866-61A92078-D08E-4876-8038-F79E50C54E6DQ28303698-326C6B00-E5DC-4DE2-999A-3FB88FB281CC
P2860
TGF-beta signaling blockade inhibits PTHrP secretion by breast cancer cells and bone metastases development.
description
1999 nî lūn-bûn
@nan
1999 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
1999 թվականի հունվարին հրատարակված գիտական հոդված
@hy
1999年の論文
@ja
1999年論文
@yue
1999年論文
@zh-hant
1999年論文
@zh-hk
1999年論文
@zh-mo
1999年論文
@zh-tw
1999年论文
@wuu
name
TGF-beta signaling blockade in ...... d bone metastases development.
@ast
TGF-beta signaling blockade in ...... d bone metastases development.
@en
type
label
TGF-beta signaling blockade in ...... d bone metastases development.
@ast
TGF-beta signaling blockade in ...... d bone metastases development.
@en
prefLabel
TGF-beta signaling blockade in ...... d bone metastases development.
@ast
TGF-beta signaling blockade in ...... d bone metastases development.
@en
P2093
P2860
P356
P1476
TGF-beta signaling blockade in ...... d bone metastases development.
@en
P2093
B G Grubbs
J M Chirgwin
J Massagué
K Selander
P2860
P304
P356
10.1172/JCI3523
P407
P577
1999-01-01T00:00:00Z